menTOR.
Doctoral Network
The multi-disciplinary training network MENTOR focuses on the mTOR (mammalian/mechanistic Target Of Rapamycin) network, a central signaling hub that integrates, nutritional cues and controls cell growth and metabolism. Aberrant mTOR activity underlies a wide range of pathologies, including age-related diseases with high incidence such as cancer, obesity, and diabetes as well as rare genetic conditions, termed mTORopathies, characterized by tumor formation, polycystic kidneys, and brain manifestations. New mechanistic insights into mTORopathies will improve treatment for people living with rare conditions through strategies of personalized medicine and will open new therapeutic avenues for severe age-related pathologies. MSCA-DN MENTOR program will involve 18 doctoral candidates with the overall goal of understanding and treating mTORopathies while maximizing the impact towards research and training for cancer, metabolic syndromes, and age-related diseases.
Client
Services
Date
Assignments
A recruitment-focused version of the MENTOR website
menTOR: Winner of the MSCA Doctoral Networks 2023
An Interdisciplinary Approach to Research & Training
The MENTOR project, coordinated by Dr Mario Pende at Université Paris Cité, is one the 17 French winners of the MSCA Doctoral Networks call for project proposals. The project brings together 15 laboratories specialising in chemistry, biology and health. Joint funding from the European Union and Switzerland will enable the recruitment of 18 PhD students, each of whom will work in one of the 15 laboratories related to their field of study. “The idea of the project is to get students in chemistry, biology and medicine to work together,” explains Dr. Mario Pende. Students will be trained through collaborative research, as well as through thematic schools planned as part of the programme.
Mario PENDE, Inserm / Université Paris Cité
A bespoke graphic charter
Have a project in mind?
working together
Send a message.